Crossmark Global Holdings Inc. Has $344,000 Stock Position in RadNet, Inc. (NASDAQ:RDNT)

Crossmark Global Holdings Inc. increased its holdings in shares of RadNet, Inc. (NASDAQ:RDNT) by 6.3% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 4,958 shares of the medical research company’s stock after purchasing an additional 296 shares during the period. Crossmark Global Holdings Inc.’s holdings in RadNet were worth $344,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of RDNT. UniSuper Management Pty Ltd acquired a new position in shares of RadNet during the 1st quarter worth approximately $683,000. Janus Henderson Group PLC lifted its holdings in shares of RadNet by 108.6% during the 1st quarter. Janus Henderson Group PLC now owns 64,029 shares of the medical research company’s stock worth $3,112,000 after acquiring an additional 33,335 shares during the period. Sei Investments Co. boosted its position in shares of RadNet by 18.8% during the 1st quarter. Sei Investments Co. now owns 65,899 shares of the medical research company’s stock worth $3,207,000 after acquiring an additional 10,430 shares in the last quarter. Quadrature Capital Ltd bought a new position in RadNet in the first quarter valued at approximately $1,049,000. Finally, Bessemer Group Inc. raised its position in RadNet by 7.9% during the first quarter. Bessemer Group Inc. now owns 250,317 shares of the medical research company’s stock valued at $12,179,000 after purchasing an additional 18,386 shares in the last quarter. Institutional investors and hedge funds own 77.90% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have weighed in on RDNT. Truist Financial raised their target price on RadNet from $70.00 to $80.00 and gave the company a “buy” rating in a report on Monday, September 23rd. Barclays raised RadNet from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $57.00 to $79.00 in a research note on Friday, September 6th. Jefferies Financial Group boosted their target price on RadNet from $75.00 to $80.00 and gave the stock a “buy” rating in a research note on Thursday, September 19th. Finally, Sidoti upgraded shares of RadNet to a “strong-buy” rating in a research note on Friday, October 4th. One equities research analyst has rated the stock with a sell rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $74.75.

RadNet Price Performance

Shares of RDNT opened at $79.58 on Monday. The company has a quick ratio of 2.12, a current ratio of 2.16 and a debt-to-equity ratio of 0.89. The stock has a market cap of $5.89 billion, a PE ratio of -1,136.69 and a beta of 1.75. RadNet, Inc. has a 12-month low of $31.36 and a 12-month high of $93.65. The business has a 50-day simple moving average of $69.29 and a two-hundred day simple moving average of $63.09.

Insider Activity

In other news, EVP Michael N. Murdock sold 15,000 shares of RadNet stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $62.78, for a total transaction of $941,700.00. Following the transaction, the executive vice president now owns 48,144 shares in the company, valued at approximately $3,022,480.32. The trade was a 23.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 5.12% of the stock is currently owned by insiders.

RadNet Profile

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.